«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:

21

期数:

2020年11期

页码:

1617-1621

栏目:

论　著

出版日期:

2020-11-28

文章信息/Info

Title:

Analysis on mortality and potential years of life lost of malignant tumors in Pingshan district of Shenzhen from2015to2018

作者:

王玲; 陈伟文; 张彩娟; 何志明; 吴能简

深圳市坪山区疾病预防控制中心，广东 深圳 518118

Author(s):

WANGLing; CHENWei-wen; ZHANGCai-juan; HEZhi-ming; WUNeng-jian

Pingshan CenterforDiseaseControlandPrevention,Shenzhen,Guangdong518118,China Correspondingauthor:WUNeng-jian,E?mail:1914214330@qq.com

关键词:

恶性肿瘤; 死亡率; 潜在减寿年数; 潜在减寿分析

Keywords:

Malignant tumors;  Mortality rate;  Potential years of life lost;  Potential life loss analysis

分类号:

R73

DOI:

-

摘要:

目的 分析2015—2018年深圳市坪山区居民恶性肿瘤的死亡特征，为制定相关卫生政策、开展肿瘤防治 工作提供科学依据。方法 收集人口死亡信息登记管理系统中2015—2018年深圳市坪山区居民的恶性肿瘤死亡 监测数据，计算粗死亡率、标化死亡率、潜在减寿年数、潜在减寿率等指标，掌握当地居民的恶性肿瘤死亡水平 及变化趋势等死亡特征。结果 2015—2018年恶性肿瘤粗死亡率为17.35/10万~22.43/10万，标化死亡率为 39.61/10万~55.15/10万，粗死亡率和标化死亡率的年度变化趋势均不明显，死亡率年度变化百分比（APC）无 统计学意义（P>0.05）。2015—2018年，男性年均标化死亡率高于女性，差异有统计学意义（P<0.01）。男性 肺癌、肝癌和食管癌年均标化死亡率均高于女性，差异均有统计学意义（P<0.05）。45~64岁年龄组和≥65岁 年龄组男性恶性肿瘤年均年龄别死亡率均高于女性，差异均有统计学意义（P<0.01）。2015—2018年，男性恶性 肿瘤标化潜在减寿年数、标化潜在减寿率均高于女性。男性各种恶性肿瘤疾病的标化潜在减寿年数、标化潜在 减寿率均高于女性。结论 恶性肿瘤防治应从45岁开始，男性是防治的重点人群，应根据不同的年龄段和性 别，做好筛查和早诊早治工作，以降低恶性肿瘤的发病率和死亡率。

Abstract:

Objective To analyze death characteristics of malignant tumors in Pingshan district of Shen-zhen from 2015 to 2018. Methods The surveillance data of malignant tumor from2015 to 2018 in Pingshan district of Shenzhen were collected from the "population death information registration manage-ment system". To know the death level and trend of the malignant tumors in local residents, crude mortality rate（CMR）, standardized mortality rate（SMR）, potential years of life lost（PYLL）, standardized potential years of life lost（SPYLL）, potential years of life lost rate（PYLLR）, and standardized potential years of life lost rate （SPYLLR）were calculated. Results From 2015 to 2018, the annual CMR of malignant tumors in general population was 17.35/100 000 to 22.43/100 000, and the annual SMR was 39.61/100 000 to 55.15/100 000. The annual change trends of crude and standardized mortality rates were not significant（P>0.05）. The average annual SMR of malignant tu-mors in men was higher than that in women（P<0.01）. The average annual SMRs of lung cancer, liver cancer, and esophageal cancer in men were higher than those in women （all P<0.05）. In the age groups 45-64 years and 65 years and over, the average annual age-specific mortality rate of ma-lignant tumors in men was higher than that in women （all P<0.01）. From 2015 to 2018, SPYLL and SPYLLR in men were higher than those in women. SPYLL and SPYLLR of various malignant tumor diseases in men were all higher than those in women. Conclusion Prevention and treatment of malignant tumors should start at age45, and the key populations for malignant tumor prevention and treatment are men. According to different age and gender, screening and early diagnosis and treatment should be conducted to reduce the incidence and mortality of malignant tumors.

参考文献/References:

[1] 曹毛毛,陈万青.中国恶性肿瘤流行情况及防控现状[J].中国肿瘤 临床,2019,46(3):145-149. [2] 王伟进,张晓路.中国癌症的现状与疾病负担[J].中国经济报告, 2019(4):63-73. [3] Kim HJ, Fay MP, Feuer EJ,et al. Permutation tests for joinpoint regression with applications to cancer rates [J]. Stat Med,2000,19(3):335-351. [4] 方积乾.卫生统计学[M].7版.北京:人民卫生出版社,2013:382. [5] 罗家有,高尔生,顾杏元.中国人口减寿年数及减寿率分析[J].人 口与经济,1991(5):30-34,23. [6] 桑瑞兰.标准化率的假设检验及其简化处理法[J].承德医学院学 报,1997(3):228-230. [7] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析 [J].中华肿瘤杂志,2019,41(1):19-28. [8] 夏亮,孟瑞琳,许燕君,等.2013年广东省肿瘤登记地区恶性肿瘤 发病与死亡分析[J].中国肿瘤,2017,26(11):829-837. [9] 杨佳,杜振华,李琰琰,等.2018年山东省肥城市户籍居民主要恶 性肿瘤死亡及减寿分析[J].中国肿瘤,2019,28(11):845-851. [10] 王莹,周敬文,周林,等.济南市居民2011-2016年恶性肿瘤死亡 流行趋势及减寿分析[J].中国卫生统计,2018,35(6):922-925. [11] 彭香红.南京市某化工园区2008-2017年居民恶性肿瘤死亡及减 寿分析[J].中国初级卫生保健,2018,32(11):42-45.

备注/Memo

备注/Memo:

基金项目：2018年深圳市坪山区卫生系统科研项目（201861） 作者简介：王玲，博士，主管医师，研究方向：慢性病管理、预防和控制 通信作者：吴能简，E-mail:1914214330@qq.com

常用功能

更新日期/Last Update: 2020-11-28